Bristol Myers Squibb Stock Market Value

BMY Stock  USD 53.25  0.70  1.33%   
Bristol Myers' market value is the price at which a share of Bristol Myers trades on a public exchange. It measures the collective expectations of Bristol Myers Squibb investors about its performance. Bristol Myers is trading at 53.25 as of the 28th of March 2024; that is 1.33 percent increase since the beginning of the trading day. The stock's open price was 52.55.
With this module, you can estimate the performance of a buy and hold strategy of Bristol Myers Squibb and determine expected loss or profit from investing in Bristol Myers over a given investment horizon. Check out Bristol Myers Correlation, Bristol Myers Volatility and Bristol Myers Alpha and Beta module to complement your research on Bristol Myers.
Symbol

Bristol-Myers Squibb Price To Book Ratio

Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.09)
Dividend Share
2.31
Earnings Share
3.86
Revenue Per Share
21.753
Quarterly Revenue Growth
0.006
The market value of Bristol-Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bristol Myers 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bristol Myers' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bristol Myers.
0.00
02/27/2024
No Change 0.00  0.0 
In 30 days
03/28/2024
0.00
If you would invest  0.00  in Bristol Myers on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding Bristol Myers Squibb or generate 0.0% return on investment in Bristol Myers over 30 days. Bristol Myers is related to or competes with Agilent Technologies, Mustang Bio, Moleculin Biotech, Seres Therapeutics, Madrigal Pharmaceuticals, Equillium, and Kineta. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwi... More

Bristol Myers Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bristol Myers' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bristol Myers Squibb upside and downside potential and time the market with a certain degree of confidence.

Bristol Myers Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bristol Myers' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bristol Myers' standard deviation. In reality, there are many statistical measures that can use Bristol Myers historical prices to predict the future Bristol Myers' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bristol Myers' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
52.0853.2554.42
Details
Intrinsic
Valuation
LowRealHigh
51.0552.2253.39
Details
Naive
Forecast
LowNextHigh
50.8752.0453.21
Details
26 Analysts
Consensus
LowTargetHigh
65.1371.5779.44
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bristol Myers. Your research has to be compared to or analyzed against Bristol Myers' peers to derive any actionable benefits. When done correctly, Bristol Myers' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bristol-Myers Squibb.

Bristol-Myers Squibb Backtested Returns

We consider Bristol Myers very steady. Bristol-Myers Squibb secures Sharpe Ratio (or Efficiency) of 0.0734, which signifies that the company had a 0.0734% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Bristol Myers Squibb, which you can use to evaluate the volatility of the firm. Please confirm Bristol Myers' Mean Deviation of 0.8573, risk adjusted performance of 0.0439, and Downside Deviation of 1.22 to double-check if the risk estimate we provide is consistent with the expected return of 0.0867%. Bristol Myers has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.51, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bristol Myers' returns are expected to increase less than the market. However, during the bear market, the loss of holding Bristol Myers is expected to be smaller as well. Bristol-Myers Squibb right now shows a risk of 1.18%. Please confirm Bristol-Myers Squibb sortino ratio, as well as the relationship between the semi variance and rate of daily change , to decide if Bristol-Myers Squibb will be following its price patterns.

Auto-correlation

    
  0.28  

Poor predictability

Bristol Myers Squibb has poor predictability. Overlapping area represents the amount of predictability between Bristol Myers time series from 27th of February 2024 to 13th of March 2024 and 13th of March 2024 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bristol-Myers Squibb price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current Bristol Myers price fluctuation can be explain by its past prices.
Correlation Coefficient0.28
Spearman Rank Test0.13
Residual Average0.0
Price Variance0.24

Bristol-Myers Squibb lagged returns against current returns

Autocorrelation, which is Bristol Myers stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bristol Myers' stock expected returns. We can calculate the autocorrelation of Bristol Myers returns to help us make a trade decision. For example, suppose you find that Bristol Myers has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Bristol Myers regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bristol Myers stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bristol Myers stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bristol Myers stock over time.
   Current vs Lagged Prices   
       Timeline  

Bristol Myers Lagged Returns

When evaluating Bristol Myers' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bristol Myers stock have on its future price. Bristol Myers autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bristol Myers autocorrelation shows the relationship between Bristol Myers stock current value and its past values and can show if there is a momentum factor associated with investing in Bristol Myers Squibb.
   Regressed Prices   
       Timeline  

Bristol Myers Investors Sentiment

The influence of Bristol Myers' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bristol. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Bristol Myers' public news can be used to forecast risks associated with an investment in Bristol. The trend in average sentiment can be used to explain how an investor holding Bristol can time the market purely based on public headlines and social activities around Bristol Myers Squibb. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bristol Myers' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bristol Myers' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bristol Myers' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Bristol Myers.

Bristol Myers Implied Volatility

    
  26.54  
Bristol Myers' implied volatility exposes the market's sentiment of Bristol Myers Squibb stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bristol Myers' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bristol Myers stock will not fluctuate a lot when Bristol Myers' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bristol Myers in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bristol Myers' short interest history, or implied volatility extrapolated from Bristol Myers options trading.

Pair Trading with Bristol Myers

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bristol Myers position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bristol Stock

  0.69MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr

Moving against Bristol Stock

  0.7MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
  0.6MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.56KA Kineta Inc Report 29th of March 2024 PairCorr
  0.56VBIV VBI Vaccines Financial Report 20th of May 2024 PairCorr
The ability to find closely correlated positions to Bristol Myers could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bristol Myers when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bristol Myers - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bristol Myers Squibb to buy it.
The correlation of Bristol Myers is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bristol Myers moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bristol-Myers Squibb moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bristol Myers can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bristol-Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol Myers' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock:
Check out Bristol Myers Correlation, Bristol Myers Volatility and Bristol Myers Alpha and Beta module to complement your research on Bristol Myers.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Bristol Stock analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bristol Myers technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bristol Myers technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bristol Myers trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...